Aktuelles aus der Forschung

• Literatur

• 1 Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 2008; 65: 727-732
• 2 Cramer SP, Modvig S, Simonsen HJ et al. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis. Brain 2015; pii: awv203 [Epub ahead of print]
• 3 Bechmann I, Galea I, Perry VH. What is the blood-brain barrier (not)?. Trends Immunol 2007; 28: 5-11
• 4 Fox RJ, Cree BA, De Seze J et al. MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study. Neurology 2014; 82: 1491-1498
• 5 Kappos L, Radue EW, Comi G et al. Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS. Neurology 2015; 85: 29-39